感染管理市場：製品別（滅菌（過酸化水素、ETO、ガンマ、Eビーム）、消毒（ワイプ、液体、消毒器）、サービス、ガウン、内視鏡リプロセシング）、エンドユーザー別（病院・クリニック、医薬品） - 2029年までの世界予測

Infection Control Market by Product (Sterilization (Hydrogen Peroxide, EtO, Gamma, E-Beam), Disinfection (Wipes, Liquids, Disinfectors), Services, Gowns, Endoscope Reprocessing), End User (Hospital & Clinics, Pharmaceuticals) - Global Forecast to 2029

感染管理市場は2024年に推定510億米ドルと評価され、予測期間中の年平均成長率は6.3%で、2029年には692億米ドルに達すると予測されている。感染管理市場を牽引する最近の主なトレンドには、抗菌性表面への注目の... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2024年2月28日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	616	694	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

感染管理市場は2024年に推定510億米ドルと評価され、予測期間中の年平均成長率は6.3%で、2029年には692億米ドルに達すると予測されている。感染管理市場を牽引する最近の主なトレンドには、抗菌性表面への注目の高まり、UV-C消毒技術の採用、ポイントオブケア検査の需要拡大などがある。これらの傾向は、感染予防に対する意識の高まり、規制の義務化、効率的かつ効果的な医療実践の必要性などが背景にある。
感染管理市場における機会としては、先端技術の採用拡大、新興国における感染予防需要の高まり、医療関連感染に対する意識の高まりなどが挙げられる。このような機会は、技術革新、市場参入の拡大、世界的な感染管理ソリューションへの投資拡大により、市場の成長を促進することができます。

"内視鏡リプロセシング製品セグメントは、予測期間中、製品別に感染制御市場で最も高い成長を目撃すると予測される。"
感染管理市場は、製品によって滅菌製品・サービス、消耗品・付属品、洗浄・消毒製品、保護バリア、内視鏡リプロセス製品に大別される。内視鏡リプロセシング製品セグメントは、予測期間中、製品別感染制御市場で最も高い成長を遂げると予測されている。内視鏡リプロセシング製品市場は成長し、大きな注目と優位性を獲得している。この分野は、医療処置に使用される内視鏡機器に特化した、必要不可欠な滅菌・消毒ソリューションを提供することに特化している。同分野の優位性は、世界的に内視鏡処置の利用が増加していることに加え、医療関連感染を防止するために効果的な再処理を義務付ける規制要件が厳しくなっていることに起因している。その結果、このセグメントは、患者の安全と感染防止基準の維持に重要な役割を果たすため、堅調な成長を続けている。

"エンドユーザー別では、病院・診療所が最も高い市場シェア"
病院・診療所は、感染制御市場において最大のエンドユーザー分野を代表し、いくつかの重要な要因によって大きなシェアを占めている。医療サービスの主要な提供者である病院と診療所は、患者の安全を確保し、高水準の医療を維持するために感染管理を優先している。こうした環境では医療関連感染（HAI）が蔓延しているため、感染制御製品やサービスの需要が高まっている。
さらに、病院や診療所の数が世界的に増加していることと、外科手術の実施件数が増加していることが、この分野の市場成長をさらに促進している。さらに、慢性疾患や感染症に罹患しやすい高齢者人口の増加が、医療施設における感染防止対策の需要に寄与している。感染防止基準や規制の改善を目的とした政府の取り組みも、病院や診療所における市場成長の原動力となっており、感染管理市場における主要エンドユーザー層としての地位を強化している。

"アジア太平洋市場は予測期間中に最も高い成長を目撃する"
2022年、アジア太平洋地域は感染制御市場において最も高い成長率を占め、インドや中国のような国々は最も高い成長が見込まれる地域として際立っている。同地域の感染管理市場の成長を促進する主な要因は、同地域の医療インフラの拡大、高度な感染管理技術の採用の増加、感染防止対策の強化を目的とした政府の支援イニシアティブなどである。

本レポートで参照した感染管理市場の主要参入企業（供給側）の内訳は以下の通りである：

- 企業タイプ別ティア1：55％、ティア2：30％、ティア3：15
- 役職別Cレベル：28％、ディレクターレベル：43％、その他：39%
- 地域別北米：35％、欧州：20％、アジア太平洋地域：30％、ラテンアメリカ：7％、中東・アフリカ：5％、GCC諸国：3％：3%

感染管理市場に参入している主な企業は、STERIS plc.(米国）、Getinge AB（スウェーデン）、Ecolab, Inc.（米国）、3M Company（米国）、Advanced Sterilization Products（米国）、Sotera Health LLC（米国）、MMM Group（ドイツ）、MATACHANA GROUP（スペイン）、Belimed AG（スイス）、Metrex Research LLC（米国）、Reckitt Benckiser（英国）、Pal International（英国）、オリンパス株式会社（日本）である。Melag Medizintechnik GmbH & Co.KG（ドイツ）、Miele Group（ドイツ）、Systec GmbH & Co.KG（ドイツ）、Contec, Inc.（米国）、Continental Equipment Company（米国）、MEDALKAN（ギリシャ）、C.R.M. S.R.L. Medical Equipment（イタリア）、Spire Integrated Solutions（米国）、

調査対象範囲
この調査レポートは、様々なセグメントにわたる感染制御市場を対象としています。製品＆サービス別、エンドユーザー別、地域別など、さまざまなセグメントにわたる市場規模や成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品・事業内容、最近の動向、主要市場戦略などに関する主要な見解も掲載しています。

レポート購入の理由
本レポートは、感染制御市場全体とサブセグメントにおける収益数の最も近い近似値に関する情報を提供することで、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より良い事業の位置付けと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
 主な促進要因（医療関連感染（HAI）の蔓延、手術件数の増加、再処理技術の進歩、食品の滅菌・消毒の重視の高まり、滅菌機器技術の進歩、製薬会社、医療機器メーカー、病院におけるアウトソーシングサービスの傾向の高まり）、抑制要因（再処理された器具の安全性に対する懸念の高まり、化学消毒剤の使用に伴う影響、内視鏡の再処理に関連する高コストと発展途上国における限られた償還、）、機会（発展途上国における医療機器と製薬会社の普及拡大、電子ビーム滅菌の利用拡大、エチレンオキサイド滅菌の再統合）、課題（高度医療機器の滅菌、表面消毒の代替方法、シングルユースの医療用不織布と機器の採用増加）。
- 市場への浸透：世界の感染制御市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報。製品・サービス別、エンドユーザー別、地域別に市場を分析しています。
- 製品の強化/革新：世界の感染管理市場における今後の動向と製品発売に関する詳細な洞察。
- 市場開発：製品・サービス別、エンドユーザー別、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化：世界の感染制御市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報。
- 競合評価：世界の感染制御市場における主要企業の市場シェア、成長戦略、製品・サービス提供、能力を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 68
1.1 STUDY OBJECTIVES 68
1.2 MARKET DEFINITION 68
1.2.1 PRODUCT DEFINITION 69
1.2.2 END USER DEFINITION 69
1.2.3 INCLUSIONS & EXCLUSIONS 70
1.3 MARKET SCOPE 71
1.3.1 MARKETS COVERED 71
1.3.2 YEARS CONSIDERED 72
1.3.3 CURRENCY CONSIDERED 72
TABLE 1 STANDARD CURRENCY CONVERSION RATES 73
1.4 STAKEHOLDERS 73
1.5 SUMMARY OF CHANGES 73
1.6 RECESSION IMPACT 74
2 RESEARCH METHODOLOGY 75
2.1 RESEARCH DATA 75
FIGURE 1 RESEARCH DESIGN 75
2.1.1 SECONDARY DATA 76
2.1.1.1 Key data from secondary sources 77
2.1.2 PRIMARY DATA 78
FIGURE 2 PRIMARY SOURCES 78
2.1.2.1 Key data from primary sources 79
2.1.2.2 Key industry insights 80
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 80
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 81
2.2 MARKET SIZE ESTIMATION 81
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 82
FIGURE 6 STERILIZATION MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION (STERIS PLC) 82
FIGURE 7 ENDOSCOPE REPROCESSING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION (ASP) 83
FIGURE 8 TOP-DOWN APPROACH 83
FIGURE 9 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT 85
FIGURE 10 MARKET SIZE ESTIMATION: STERILIZATION EQUIPMENT 85
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029): IMPACT LEVEL OF CAGR 86
FIGURE 12 CAGR PROJECTIONS 87
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 88
FIGURE 13 DATA TRIANGULATION METHODOLOGY 88
2.4 MARKET RANKING ANALYSIS 89
2.5 STUDY ASSUMPTIONS 89
2.6 RISK ASSESSMENT 90
2.7 LIMITATIONS 90
2.7.1 METHODOLOGY-RELATED LIMITATIONS 90
2.8 RECESSION IMPACT ANALYSIS 90
3 EXECUTIVE SUMMARY 91
FIGURE 14 CLEANING & DISINFECTION PRODUCTS TO BE LARGEST SEGMENT DURING FORECAST PERIOD 91
FIGURE 15 STERILIZATION EQUIPMENT SEGMENT TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 92
FIGURE 16 DISINFECTANTS TO BE LEADING SEGMENT DURING FORECAST PERIOD 93
FIGURE 17 ENDOSCOPE REPROCESSING CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023 94
FIGURE 18 MEDICAL NONWOVENS TO BE LEADING SEGMENT DURING FORECAST PERIOD 94
FIGURE 19 HOSPITALS & CLINICS TO DOMINATE INFECTION CONTROL MARKET DURING FORECAST PERIOD 95
FIGURE 20 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR INFECTION CONTROL 96
4 PREMIUM INSIGHTS 97
4.1 SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN INFECTION CONTROL MARKET 97
FIGURE 21 HIGH INCIDENCE OF HAIS AND GROWING FOCUS ON FOOD STERILIZATION AND DISINFECTION TO DRIVE MARKET 97
4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY 98
FIGURE 22 JAPAN LED INFECTION CONTROL MARKET IN ASIA PACIFIC IN 2023 98
4.3 INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 99
FIGURE 23 CHINA TO REGISTER HIGHEST REVENUE GROWTH DURING FORECAST PERIOD 99
4.4 INFECTION CONTROL MARKET, BY REGION (2021–2029) 100
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE INFECTION CONTROL MARKET DURING FORECAST PERIOD 100
4.5 INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS 101
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 101
5 MARKET OVERVIEW 102
5.1 INTRODUCTION 102
5.2 MARKET DYNAMICS 102
FIGURE 26 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN INFECTION CONTROL MARKET 102
5.2.1 MARKET DRIVERS 103
5.2.1.1 Rising prevalence of healthcare-associated infections (HAIs) 103
5.2.1.2 Growing number of surgeries 103
5.2.1.3 Advancement in reprocessing technologies 104
5.2.1.4 Rising emphasis on sterilization and disinfection of food 104
5.2.1.5 Advancements in sterilization equipment technology 104
5.2.1.6 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals 105
5.2.2 MARKET RESTRAINTS 105
5.2.2.1 Growing concerns about safety of reprocessed instruments 105
5.2.2.2 Consequences associated with use of chemical disinfectants 106
5.2.2.3 High cost associated with endoscopy reprocessing coupled with limited reimbursements in developing nations 106
5.2.3 MARKET OPPORTUNITIES 107
5.2.3.1 Increasing prevalence of medical devices and pharmaceutical companies in developing nations 107
5.2.3.2 Growing utilization of E-beam sterilization 108
5.2.3.3 Reintegration of ethylene oxide sterilization 108
5.2.4 MARKET CHALLENGES 109
5.2.4.1 Sterilization of advanced medical devices 109
5.2.4.2 Alternative methods for surface disinfection 109
5.2.4.3 Increasing adoption of single-use medical nonwovens and devices 110
5.3 INDUSTRY TRENDS 110
5.3.1 ARTIFICIAL INTELLIGENCE (AI) INTEGRATION WITH INFECTION CONTROL 110
5.3.2 POINT-OF-CARE TESTING IN INFECTION CONTROL 110
5.4 VALUE CHAIN ANALYSIS 111
FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 112
5.5 TECHNOLOGY ANALYSIS 112
5.5.1 SUPERCRITICAL CO2 TECHNOLOGY 112
5.5.2 ULTRA-HIGH-PRESSURE STERILIZATION 113
5.5.3 NITROGEN DIOXIDE (NO2) 113
5.5.4 PULSED ELECTRIC FIELD (PEF) STERILIZATION 113
5.5.5 PLASMA STERILIZATION 114
5.6 PORTER’S FIVE FORCES ANALYSIS 114
TABLE 2 INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS 114
5.6.1 THREAT OF NEW ENTRANTS 114
5.6.2 THREAT OF SUBSTITUTES 115
5.6.3 BARGAINING POWER OF SUPPLIERS 115
5.6.4 BARGAINING POWER OF BUYERS 116
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 116
5.7 REGULATORY LANDSCAPE 116
5.7.1 REGULATORY ANALYSIS 116
5.7.1.1 North America 116
5.7.1.1.1 US 116
FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 117
5.7.1.1.2 Canada 117
TABLE 3 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING 118
5.7.1.2 Europe 118
TABLE 4 STERILIZATION STANDARDS IN EUROPEAN UNION 119
5.7.1.3 Asia Pacific 119
5.7.1.3.1 Japan 119
TABLE 5 GUIDELINES FOR INDICATORS 120
TABLE 6 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES 120
5.7.1.3.2 China 121
5.7.1.3.3 Australia 121
5.7.1.4 Latin America 121
5.7.1.4.1 Brazil 121
5.7.1.4.2 Mexico 121
5.7.1.5 Middle East 122
5.7.1.6 Africa 122
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 11 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
5.8 PATENT ANALYSIS 124
5.8.1 PATENT PUBLICATION TRENDS FOR INFECTION CONTROL 124
FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2014–FEBRUARY 2024) 124
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 125
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION CONTROL PATENTS, JANUARY 2014–FEBRUARY 2024 125
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION CONTROL PATENTS, JANUARY 2014–FEBRUARY 2024 126
TABLE 12 LIST OF PATENTS IN INFECTION CONTROL MARKET, 2021–2024 126
5.9 TRADE ANALYSIS 128
TABLE 13 TOP EXPORTERS OF STERILIZERS FOR MEDICAL, SURGICAL, AND LABORATORY USE 128
5.10 KEY CONFERENCES & EVENTS 129
TABLE 14 INFECTION CONTROL MARKET: KEY CONFERENCES & EVENTS (2024) 129

5.11 ECOSYSTEM/MARKET MAP 130
FIGURE 32 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS 130
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 131
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 131
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS 131
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS (%) 131
5.12.2 BUYING CRITERIA 131
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 131
TABLE 16 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS 132
5.13 UNMET NEEDS: INFECTION CONTROL MARKET 132
5.14 ADJACENT MARKET ANALYSIS 134
FIGURE 35 ADJACENT MARKETS OF INFECTION CONTROL MARKET 134
5.15 SUPPLY CHAIN ANALYSIS 134
FIGURE 36 SUPPLY CHAIN ANALYSIS: INFECTION CONTROL MARKET 135
5.16 PRICING ANALYSIS 135
5.16.1 AVERAGE SELLING PRICE OF STERILIZERS (PRODUCT USED FOR INFECTION CONTROL), BY TYPE 135
TABLE 17 AVERAGE SELLING PRICE OF STERILIZERS, BY TYPE, 2022 135
5.16.2 AVERAGE SELLING PRICE OF DRY HEAT STERILIZERS (PRODUCT USED FOR INFECTION CONTROL), BY REGION 136
TABLE 18 AVERAGE SELLING PRICE OF DRY HEAT STERILIZERS, BY REGION, 2023 136
5.17 AI IN INFECTION CONTROL TOOLS LIKE STERILIZATION EQUIPMENT 136
5.18 REIMBURSEMENT ANALYSIS 137
5.19 INVESTMENT AND FUNDING SCENARIO: INFECTION CONTROL MARKET 138
FIGURE 37 FUNDING AND INVESTMENTS IN INFECTION CONTROL MARKET INCREASED IN 2021 138
6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE 139
6.1 INTRODUCTION 140
TABLE 19 COMMONLY USED INFECTION CONTROL CHEMICALS 140
TABLE 20 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION) 142
6.2 STERILIZATION PRODUCTS & SERVICES 142
TABLE 21 KEY PLAYERS PROVIDING STERILIZATION PRODUCTS AND SERVICES 143
TABLE 22 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 144
TABLE 23 STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 145
6.2.1 STERILIZATION EQUIPMENT 145
TABLE 24 KEY PLAYERS PROVIDING STERILIZATION EQUIPMENT 146
TABLE 25 STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 148
TABLE 26 STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 149
6.2.1.1 Heat sterilization equipment 149
TABLE 27 KEY PLAYERS PROVIDING HEAT STERILIZATION EQUIPMENT 150
TABLE 28 HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 151
TABLE 29 HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 152
6.2.1.1.1 Moist heat sterilizers 152
6.2.1.1.1.1 Versatility of moist heat sterilizers to drive market 152
TABLE 30 MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 153
TABLE 31 MOIST HEAT STERILIZERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 154
6.2.1.1.2 Dry heat sterilizers 155
6.2.1.1.2.1 Rising demand for heat-sensitive instruments to drive growth 155
TABLE 32 DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS 155
TABLE 33 DRY HEAT STERILIZERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 156
6.2.1.2 Low-temperature sterilization 157
TABLE 34 LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS 157
TABLE 35 LOW-TEMPERATURE STERILIZATION MARKET, BY TYPE, 2021–2029 (USD MILLION) 158
TABLE 36 LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 159
6.2.1.2.1 Hydrogen peroxide sterilization 159
6.2.1.2.1.1 Broad spectrum activity of hydrogen peroxide sterilization to fuel market growth 159
TABLE 37 HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 160
TABLE 38 HYDROGEN PEROXIDE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 161
6.2.1.2.2 Ethylene oxide (EtO) sterilization 161
6.2.1.2.2.1 High penetration capability of EtO sterilization to propel market growth 161
TABLE 39 ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS 162
TABLE 40 ETO STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 163
6.2.1.2.3 Formaldehyde sterilization 163
6.2.1.2.3.1 Increasing efficacy of formaldehyde sterilization to drive market 163
TABLE 41 FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS 164
TABLE 42 FORMALDEHYDE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 165
6.2.1.2.4 Other low-temperature sterilization products 165
TABLE 43 OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 166
6.2.1.3 Radiation sterilization 167
6.2.1.3.1 Adoption in pharmaceutical and biopharmaceutical sectors to drive market 167
TABLE 44 RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 167
TABLE 45 RADIATION STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 168
6.2.1.4 Filtration sterilization equipment 168
6.2.1.4.1 Growing adoption in pharmaceutical and food industries to drive expansion 168
TABLE 46 FILTRATION STERILIZERS OFFERED BY KEY MARKET PLAYERS 169
TABLE 47 FILTRATION STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 171
6.2.1.5 Other sterilization equipment 171
TABLE 48 OTHER STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 172
6.2.2 CONTRACT STERILIZATION SERVICES MARKET 173
TABLE 49 CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 173
TABLE 50 CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 174
TABLE 51 CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 175
6.2.2.1 EtO sterilization services 175
6.2.2.1.1 Increasing demand for sterile medical devices to boost segment growth 175
TABLE 52 ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 176
TABLE 53 ETO STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 177
6.2.2.2 Gamma sterilization services 177
6.2.2.2.1 Increased efficiency and reliability to boost market growth 177
TABLE 54 GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 178
TABLE 55 GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 179
6.2.2.3 E-beam sterilization services 179
6.2.2.3.1 Fast processing time of E-beam sterilization to drive market 179
TABLE 56 E-BEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 180
TABLE 57 E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 181
6.2.2.4 Steam sterilization services 181
6.2.2.4.1 Reliable and versatile method across industries to drive market 181
TABLE 58 STEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 182
TABLE 59 STEAM STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 183
6.2.2.5 Other contract sterilization services 183
TABLE 60 OTHER CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS 184
TABLE 61 OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 185

6.3 CONSUMABLES & ACCESSORIES 185
TABLE 62 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 186
TABLE 63 CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 187
6.3.1 STERILIZATION INDICATORS 187
TABLE 64 STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS 188
TABLE 65 STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 189
TABLE 66 STERILIZATION INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 189
6.3.1.1 Chemical indicators 190
6.3.1.1.1 Cost effectiveness of chemical indicators to drive market 190
TABLE 67 CHEMICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 190
TABLE 68 CHEMICAL INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 191
6.3.1.2 Biological indicators 191
6.3.1.2.1 Effectiveness of biological indicators (BIs) to boost adoption 191
TABLE 69 BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS 192
TABLE 70 BIOLOGICAL INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 193
6.3.2 STERILIZATION POUCHES 193
TABLE 71 STERILIZATION POUCHES OFFERED BY KEY MARKET PLAYERS 194
TABLE 72 STERILIZATION POUCHES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 195
6.3.3 STERILIZATION LUBRICANTS 195
TABLE 73 STERILIZATION LUBRICANTS OFFERED BY KEY MARKET PLAYERS 196
TABLE 74 STERILIZATION LUBRICANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 197
6.3.4 STERILIZATION ACCESSORIES 197
TABLE 75 STERILIZATION ACCESSORIES OFFERED BY KEY MARKET PLAYERS 198
TABLE 76 STERILIZATION ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 200
6.4 CLEANING & DISINFECTION PRODUCTS 201
TABLE 77 CLEANING & DISINFECTION PRODUCTS OFFERED BY KEY MARKET PLAYERS 201
TABLE 78 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 204
TABLE 79 CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 205
6.4.1 DISINFECTANTS 205
TABLE 80 COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS 206
TABLE 81 DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 207
6.4.1.1 Disinfectants, by product type 208
TABLE 82 DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 208
6.4.1.1.1 Hand disinfectants 208
6.4.1.1.1.1 Rising awareness about health and hygiene to boost market growth 208
TABLE 83 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 209
TABLE 84 HAND DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 210
6.4.1.1.2 Surface disinfectants 210
6.4.1.1.2.1 Increasing prevalence of HAIs to drive use of surface disinfectants 210
TABLE 85 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 211
TABLE 86 SURFACE DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 212
6.4.1.1.3 Skin disinfectants 213
6.4.1.1.3.1 Rising prevalence of infectious diseases to drive growth of skin disinfectants market 213
TABLE 87 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 213
TABLE 88 SKIN DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 215
6.4.1.1.4 Instrument disinfectants 215
6.4.1.1.4.1 Growing number of surgeries to boost market growth 215
TABLE 89 INSTRUMENT DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 216
TABLE 90 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 218
6.4.1.2 Disinfectants, by formulation 218
TABLE 91 DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION) 219
6.4.1.2.1 Liquid disinfectants 219
6.4.1.2.1.1 Increased adaptability to improve hygiene in specialty clinics, hospitals, and ambulatory surgery centers to drive growth 219
TABLE 92 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 220
TABLE 93 LIQUID DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 221
6.4.1.2.2 Disinfectant wipes 221
6.4.1.2.2.1 Versatility of disinfectant wipes to boost market growth 221
TABLE 94 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 222
TABLE 95 DISINFECTANT WIPES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 223
6.4.1.2.3 Disinfectant sprays 223
6.4.1.2.3.1 Increasing use of sprays for antimicrobial control to propel growth 223
TABLE 96 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 224
TABLE 97 DISINFECTANT SPRAYS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 225
6.4.1.3 Disinfectants, by EPA classification 225
TABLE 98 DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION) 226
6.4.1.3.1 Low-level disinfectants 226
6.4.1.3.1.1 Low-level disinfectants to dominate market in future 226
TABLE 99 LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 227
6.4.1.3.2 Intermediate-level disinfectants 227
6.4.1.3.2.1 Increasing utilization of intermediate-level disinfectants to fuel growth 227
TABLE 100 INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 228
6.4.1.3.3 High-level disinfectants 228
6.4.1.3.3.1 Effectiveness in disinfecting heat-sensitive, critical, and semi-critical items to drive demand 228
TABLE 101 HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 229
6.4.2 CLEANING & DISINFECTION EQUIPMENT 230
TABLE 102 CLEANING & DISINFECTION EQUIPMENTS OFFERED BY KEY MARKET PLAYERS 230
TABLE 103 CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 231
TABLE 104 CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 232
6.4.2.1 Washer disinfectors 232
6.4.2.1.1 Efficiency in cleaning and disinfecting medical devices and equipment to drive market 232
TABLE 105 WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 233
TABLE 106 WASHER DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 234
6.4.2.2 Flusher disinfectors 234
6.4.2.2.1 Rising demand to mitigate spread of HAIs to drive market growth 234
TABLE 107 FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS 235
TABLE 108 FLUSHER DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 236
6.4.2.3 UV-ray disinfectors 236
6.4.2.3.1 Efficacy in addressing broad spectrum of microorganisms to drive market 236
TABLE 109 UV-RAY DISINFECTORS OFFERED BY KEY MARKET PLAYERS 237
TABLE 110 UV-RAY DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 238
6.4.2.4 Ultrasonic cleaners 238
6.4.2.4.1 Improved efficacy in disinfecting medical instruments to boost demand 238
TABLE 111 ULTRASONIC CLEANERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 239
6.4.2.5 Other cleaning & disinfection equipment 239
TABLE 112 OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 240
6.4.3 LUBRICANTS & CLEANING SOLUTIONS 240
6.4.3.1 Increasing significance of lubrication in reprocessing of medical devices to boost market 240
TABLE 113 LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 241
TABLE 114 LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 242
6.4.4 DISINFECTION & CLEANING ACCESSORIES 242
6.4.4.1 Stringent regulatory standards to drive demand 242
TABLE 115 DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 243
6.5 PROTECTIVE BARRIERS 244
TABLE 116 PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 117 PROTECTIVE BARRIERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 245
6.5.1 MEDICAL NONWOVENS 245
TABLE 118 MEDICAL NONWOVENS OFFERED BY KEY MARKET PLAYERS 246
TABLE 119 MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION) 247
TABLE 120 MEDICAL NONWOVENS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 247
6.5.1.1 Face masks 248
6.5.1.1.1 Increasing prevalence of respiratory diseases to drive market growth 248
TABLE 121 FACE MASKS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 249
6.5.1.2 Surgical gowns 249
6.5.1.2.1 Growing awareness about infection control to fuel growth 249
TABLE 122 LEVELS OF SURGICAL GOWNS 250
TABLE 123 SURGICAL GOWNS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 251
6.5.1.3 Surgical drapes 251
6.5.1.3.1 Increasing adoption of surgical drapes to propel market growth 251
TABLE 124 SURGICAL DRAPES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 252
6.5.2 GLOVES 253
6.5.2.1 Increasing concern about personnel safety to result in widespread adoption of gloves 253
TABLE 125 GLOVES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 254
6.5.3 COVERS & CLOSURES 254
6.5.3.1 Creating safe environments in healthcare and food industries supports market growth 254
TABLE 126 COVERS & CLOSURES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 255
6.5.4 GOGGLES 256
6.5.4.1 Growing use of protective gear in research laboratories and hospitals to positively impact market 256
TABLE 127 GOGGLES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 257
6.6 ENDOSCOPE REPROCESSING PRODUCTS 257
TABLE 128 ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 258
TABLE 129 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 259
TABLE 130 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 260
6.6.1 ENDOSCOPE REPROCESSING CONSUMABLES 260
6.6.1.1 Ensuring effectiveness and safety of endoscope reprocessing procedures to drive market growth 260
TABLE 131 ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS 261
TABLE 132 ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 262
6.6.2 ENDOSCOPE REPROCESSING EQUIPMENT 263
TABLE 133 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 134 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 264
6.6.2.1 Automated endoscope reprocessors 264
6.6.2.1.1 Enhanced efficiency of AERs compared to manual cleaning to foster growth 264
TABLE 135 AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS 265
TABLE 136 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 266
6.6.2.2 Endoscope tracking systems 266
6.6.2.3 Rising concerns about HAIs to drive demand for efficient reprocessing and traceability 266
TABLE 137 ENDOSCOPE TRACKING SYSTEMS OFFERED BY KEY MARKET PLAYERS 267
TABLE 138 ENDOSCOPE TRACKING SYSTEMS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 268
6.6.3 OTHER ENDOSCOPE REPROCESSING EQUIPMENT 268
TABLE 139 OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS 269
TABLE 140 OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 270
6.7 OTHER INFECTION CONTROL PRODUCTS 270
TABLE 141 OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION) 271
7 INFECTION CONTROL MARKET, BY END USER 272
7.1 INTRODUCTION 273
TABLE 142 INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION) 273
7.2 HOSPITALS & CLINICS 274
7.2.1 STRINGENT REGULATIONS AND STANDARDS FOR HAIS PREVENTION TO DRIVE MARKET 274
TABLE 143 EXAMPLES OF CRITICAL-ACCESS HOSPITALS IMPLEMENTING EVIDENCE-BASED PROGRAMS FOR HAIS 275
TABLE 144 INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION) 276
7.3 MEDICAL DEVICE COMPANIES 277
7.3.1 INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE GROWTH 277
TABLE 145 INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION) 278
7.4 PHARMACEUTICAL COMPANIES 279
7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET 279
TABLE 146 DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES 279
TABLE 147 INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION) 280
7.5 LIFE SCIENCE INDUSTRY 281
7.5.1 INCREASING PREVALENCE OF CLINICAL RESEARCH INITIATIVES TO PROMOTE GROWTH 281
TABLE 148 INFECTION CONTROL MARKET FOR LIFE SCIENCE INDUSTRY, BY COUNTRY, 2021–2029 (USD MILLION) 282
7.6 FOOD INDUSTRY 283
7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO DRIVE GROWTH 283
TABLE 149 INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2029 (USD MILLION) 284
7.7 OTHER END USERS 284
TABLE 150 INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION) 285
8 INFECTION CONTROL MARKET, BY REGION 286
8.1 INTRODUCTION 287
FIGURE 38 INFECTION CONTROL MARKET IN CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 287
TABLE 151 INFECTION CONTROL MARKET, BY REGION, 2021–2029 (USD MILLION) 288
8.2 NORTH AMERICA 288
8.2.1 RECESSION IMPACT 289
FIGURE 39 NORTH AMERICA: INFECTION CONTROL MARKET SNAPSHOT 290
TABLE 152 NORTH AMERICA: INFECTION CONTROL MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 291
TABLE 153 NORTH AMERICA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION) 291
TABLE 154 NORTH AMERICA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 155 NORTH AMERICA: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 156 NORTH AMERICA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 157 NORTH AMERICA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 158 NORTH AMERICA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 294
TABLE 159 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 294
TABLE 160 NORTH AMERICA: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 161 NORTH AMERICA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 162 NORTH AMERICA: DISINFECTANTS MARKET, BY PRODUCT TYPE, 2021–2029 (USD MILLION) 296
TABLE 163 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION) 296
TABLE 164 NORTH AMERICA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION) 297
TABLE 165 NORTH AMERICA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 166 NORTH AMERICA: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 298
TABLE 167 NORTH AMERICA: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION) 298
TABLE 168 NORTH AMERICA: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 298
TABLE 169 NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 299
TABLE 170 NORTH AMERICA: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION) 299
8.2.2 US 299
8.2.2.1 Rising prevalence of healthcare-associated infections (HAIs) to drive market 299
TABLE 171 US: KEY MACRO INDICATORS 300
TABLE 172 US: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION) 301
TABLE 173 US: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 174 US: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 175 US: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 176 US: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 177 US: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 178 US: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 304
TABLE 179 US: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 304
TABLE 180 US: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 305
TABLE 181 US: DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 305
TABLE 182 US: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION) 306
TABLE 183 US: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION) 306
TABLE 184 US: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 185 US: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 186 US: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 187 US: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 188 US: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 189 US: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION) 308
8.2.3 CANADA 308
8.2.3.1 Rising geriatric population to support market growth 308
TABLE 190 CANADA: KEY MACRO INDICATORS 309
TABLE 191 CANADA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION) 310
TABLE 192 CANADA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 310
TABLE 193 CANADA: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 194 CANADA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 195 CANADA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 312
TABLE 196 CANADA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 312
TABLE 197 CANADA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 198 CANADA: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 199 CANADA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 200 CANADA: DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 201 CANADA: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION) 315
TABLE 202 CANADA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION) 315
TABLE 203 CANADA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 316
TABLE 204 CANADA: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 316
TABLE 205 CANADA: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 206 CANADA: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 207 CANADA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 208 CANADA: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION) 318

ページTOPに戻る

Table of Contents

Summary

The infection control market is valued at an estimated USD 51.0 billion in 2024 and is projected to reach USD 69.2 billion by 2029, at a CAGR of 6.3% during the forecast period. Recent key trends driving the infection control market include increased focus on antimicrobial surfaces, adoption of UV-C disinfection technology, and growth in demand for point-of-care testing. These trends are driven by heightened awareness of infection prevention, regulatory mandates, and the need for efficient and effective healthcare practices.
Opportunities in the infection control market include increasing adoption of advanced technologies, rising demand for infection prevention in emerging economies, and growing awareness of healthcare-associated infections. These opportunities can drive market growth by innovation, expanding market reach, and fostering greater investment in infection control solutions worldwide.

“The endoscope reprocessing products segment is projected to witness the highest growth in the infection control market, by products, during the forecast period.”
The infection control market can be broadly classified into sterilization products & services, consumables & accessories, cleaning & disinfection products, protective barriers, and endoscope reprocessing products depending on the product. The endoscope reprocessing products segment is projected to witness the highest growth in the infection control market, by products, during the forecast period. The endoscope reprocessing products market is growing, commanding significant attention and dominance. This segment specializes in providing essential sterilization and disinfection solutions tailored specifically for endoscopic devices used in medical procedures. Its dominance is attributed to the increasing utilization of endoscopic procedures worldwide, coupled with stringent regulatory requirements mandating effective reprocessing to prevent Healthcare-Associated Infection. Consequently, the segment continues to experience robust growth due to its critical role in maintaining patient safety and infection prevention standards.

“Hospitals and clinics segment, by end-user, has the highest market share.”
Hospitals and clinics represent the largest end user segment in the infection control market, commanding a significant share due to several key factors. As primary providers of healthcare services, hospitals and clinics prioritize infection control to ensure patient safety and maintain high standards of care. The prevalence of Healthcare-Associated Infections (HAIs) within these settings drives the demand for infection control products and services.
Additionally, the increasing number of hospitals and clinics globally, coupled with the rising volume of surgical procedures performed, further fuels market growth within this segment. Moreover, the growing geriatric population, which is more susceptible to chronic diseases and infections, contributes to the demand for infection control measures in healthcare facilities. Government initiatives aimed at improving infection prevention standards and regulations also drive market growth within hospitals and clinics, reinforcing their position as the primary end user segment in the infection control market.

“Asia Pacific market to witness the highest growth during the forecast period.”
In the year 2022, the Asia Pacific region accounted for the highest growth rate in the infection control market, with countries like India and China standing out as areas with the highest growth potential. The major factors promoting the growth of the infection control market in this region are region's expanding healthcare infrastructure, increasing adoption of advanced infection control technologies, and supportive government initiatives aimed at enhancing infection prevention measures.

A breakdown of the primary participants (supply-side) for the infection control market referred to for this report is provided below:

• By Company Type: Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
• By Designation: C-level: 28%, Director-level: 43%, and Others: 39%
• By Region: North America: 35%, Europe: 20%, Asia Pacific: 30%, Latin America: 7%; Middle East & Africa: 5%, and GCC Countries: 3%

The prominent players operating in the infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Advanced Sterilization Products (US), Sotera Health LLC (US), MMM Group (Germany), MATACHANA GROUP (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), Olympus Corporation (Japan). Melag Medizintechnik GmbH & Co. KG (Germany), Miele Group (Germany), Systec GmbH & Co. KG(Germany), Contec, Inc. (US), Continental Equipment Company (US), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US),

Research Coverage:
The market study covers the infection control market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product & service, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall infection control market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
 Analysis of key drivers (Rising prevalence of healthcare-associated infections (HAIs), Growing number of surgeries, Advancement in reprocessing technologies, Rising emphasis on the sterilization and disinfection of food, Advancements in sterilization equipment technology, Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (Growing concerns about the safety of reprocessed instruments, Consequences associated with the use of chemical disinfectants, High cost associated with endoscopy reprocessing coupled with the limited reimbursements in developing nations, ), opportunities (The increasing prevalence of medical devices and pharmaceutical companies in developing nations, Growing utilization of E-beam sterilization, Reintegration of ethylene oxide sterilization) and challenges (Sterilization of Advanced Medical Devices, Alternative methods for surface disinfection, Increasing adoption of single-use medical nonwovens and devices).
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection control market. The report analyzes this market by product & service, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection control market.
• Market Development: Comprehensive information on the lucrative emerging markets by product & service, end user, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global infection control market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global infection control market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

感染管理市場：製品別（滅菌（過酸化水素、ETO、ガンマ、Eビーム）、消毒（ワイプ、液体、消毒器）、サービス、ガウン、内視鏡リプロセシング）、エンドユーザー別（病院・クリニック、医薬品） - 2029年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?